Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities

NCT04220229 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04220229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities
Lead sponsor
University of Washington
Phase
Phase 1/2
Overall status
Terminated
Start date
June 1, 2020
Completion date
October 31, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma of the extremity, stage i soft tissue sarcoma of the trunk and extremities, stage ia soft tissue sarcoma of the trunk and extremities, stage ib soft tissue sarcoma of the trunk and extremities, stage ii soft tissue sarcoma of the trunk and extremities